HUNILIFE BIOTECHNOLOGY, INC.
🇹🇼Taiwan
- Country
- 🇹🇼Taiwan
- Ownership
- Private
- Established
- 2012-11-21
- Employees
- 11
- Market Cap
- -
- Website
- http://www.hunilife.com
A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HuL001
- First Posted Date
- 2020-09-07
- Last Posted Date
- 2023-03-09
- Lead Sponsor
- HuniLife Biotechnology, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT04540770
- Locations
- 🇨🇳
Mackay Memorial Hospital, New Taipei City, Taiwan
🇨🇳National Taiwan University Hospital, Taipei, Taiwan
© Copyright 2025. All Rights Reserved by MedPath